These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1786025)

  • 21. Turkey macrophage and heterophil bactericidal activity against Pasteurella multocida.
    Harmon BG; Glisson JR; Nunnally JC
    Avian Dis; 1992; 36(4):986-91. PubMed ID: 1485882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of turkeys with cell-free culture filtrate of Pasteurella multocida: effects of dilution, iron chelation, and heterologous challenge.
    Ficken MD; Barnes HJ; Avakian AP; Carver DK
    Avian Dis; 1992; 36(4):975-85. PubMed ID: 1485881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hypovitaminosis A on the pathogenesis of Pasteurella multocida in turkeys.
    Aye PP; Morishita TY; Saif YM; Jonas M
    Avian Dis; 2000; 44(4):818-26. PubMed ID: 11195636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pasteurella multocida as the cause of disease outbreaks in commercial poultry flocks].
    Hinz KH; Lüders H
    Berl Munch Tierarztl Wochenschr; 1991 Sep; 104(9):298-303. PubMed ID: 1953629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterin-induced protection of turkeys against fowl cholera following infection with Bordetella avium.
    Rimler RB; Kunkle RA
    Avian Dis; 1998; 42(4):752-6. PubMed ID: 9876844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial purification of cross-protection factor(s) from Pasteurella multocida.
    Rimler RB
    Avian Dis; 1994; 38(4):778-89. PubMed ID: 7702511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of Pasteurella multocida serotype A:3,4 infection in turkeys: a comparison of two vaccine strains and a field isolate.
    Prantner MM; Harmon BG; Glisson JR; Mahaffey EA
    Avian Dis; 1990; 34(2):260-6. PubMed ID: 2369373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between anti-Pasteurella multocida antibody titers after CU vaccination and survival after challenge.
    Schlink GT; Olson LD
    Avian Dis; 1989; 33(3):506-10. PubMed ID: 2775097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization of membrane-associated cross-protection factor(s) of Pasteurella multocida.
    Rimler RB; Rhoades KR
    Avian Dis; 1989; 33(2):258-63. PubMed ID: 2751557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of selection for increased body weight, egg production, and shank width on the length of the incubation period of turkeys.
    Christensen VL; Noble DO; Nestort KE
    Poult Sci; 2000 May; 79(5):613-8. PubMed ID: 10824946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virulence of avian capsular serogroup B Pasteurella multocida for turkey poults.
    Rhoades KR; Rimler RB
    Avian Dis; 1988; 32(1):121-3. PubMed ID: 3382367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passive cross-protection provided by antisera directed against in-vivo-expressed antigens of Pasteurella multocida.
    Wang C; Glisson JR
    Avian Dis; 1994; 38(3):506-14. PubMed ID: 7832703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A bird-contact method of challenging turkeys with Pasteurella multocida.
    Alls AA; Appleton GS; Ipson JR
    Avian Dis; 1970 Feb; 14(1):172-8. PubMed ID: 5434435
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultrastructural location of the cross-protection factor on in vivo and in vitro grown Pasteurella multocida.
    Rimler RB; Brogden KA
    Avian Dis; 2001; 45(4):946-52. PubMed ID: 11785898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of a cross-protective antigen from Pasteurella multocida grown in vitro and in vivo.
    Rimler RB
    Avian Dis; 2001; 45(3):572-80. PubMed ID: 11569729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of plasmid acquisition on potential virulence attributes of Pasteurella multocida.
    Lee MD; Wooley RE
    Avian Dis; 1995; 39(3):451-7. PubMed ID: 8561727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mannan-binding lectin (MBL) in two chicken breeds and the correlation with experimental Pasteurella multocida infection.
    Schou TW; Permin A; Christensen JP; Cu HP; Juul-Madsen HR
    Comp Immunol Microbiol Infect Dis; 2010 May; 33(3):183-95. PubMed ID: 18922580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-protection factor(s) of Pasteurella multocida: passive immunization of turkeys against fowl cholera caused by different serotypes.
    Rimler RB
    Avian Dis; 1987; 31(4):884-7. PubMed ID: 3442539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and virulence of a Pasteurella multocida fhaB2 mutant in turkeys.
    Tatum FM; Yersin AG; Briggs RE
    Microb Pathog; 2005; 39(1-2):9-17. PubMed ID: 15998577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of selection for increased body weight in turkeys on lymphoid organ weights, phagocytosis, and antibody responses to fowl cholera and Newcastle disease-inactivated vaccines.
    Li Z; Nestor KE; Saif YM; Anderson JW; Patterson RA
    Poult Sci; 2001 Jun; 80(6):689-94. PubMed ID: 11441833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.